• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压和体能对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其相关后果的影响。(聚焦血管紧张素转换酶2(ACE2)的可能机制)

Impact of Hypertension and Physical Fitness on SARS-COV-2 and Related Consequences. (Possible Mechanisms with Focusing on ACE2).

作者信息

Kushkestani Mehdi, Parvani Mohsen, Moghadassi Mahsa, Kazemzadeh Yaser, Moradi Kiandokht

机构信息

Faculty of Physical Education and Sport Sciences, Allameh Tabataba'i University, Tehran, Iran.

Department of Exercise Physiology, Islamic Azad University, Tehran North Branch, Tehran, Iran.

出版信息

Caspian J Intern Med. 2022;13(Suppl 3):148-154. doi: 10.22088/cjim.13.0.148.

DOI:10.22088/cjim.13.0.148
PMID:35872687
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9272964/
Abstract

Hypertension disease as an absolute risk factor of Covid-19 disease has been well-proven in recent evidence. The factors such as the use of antihypertensive drugs, protein expression, and compensatory axes resulted in hypertension disease playing very important roles in the occurrence of this problem. In this review study, we first attempted to investigate the higher chance reason for Covid-19 disease in people with high blood pressure; then we examined the related mechanisms, and finally, we reported the differences and similarities between people with high blood pressure and athletes. All in all, we concluded that people who exercise regularly, the same as hypertensive patients (Compensatory mechanism) are more susceptible to COVID-19 infection due to the high concentration of ACE2 (Physiological mechanism) caused by exercise adaptation, but for the low level of ANG2 (Systematic and gene expression) these individuals (Active subjects) indicate fewer complications and severity symptoms of COVID-19 such as dyspnea, hospitalization and, heart disease compared with hypertensive patients.

摘要

高血压疾病作为新冠病毒疾病的一个绝对风险因素,在最近的证据中已得到充分证实。诸如使用抗高血压药物、蛋白质表达和代偿轴等因素,使得高血压疾病在这一问题的发生中发挥着非常重要的作用。在这项综述研究中,我们首先试图探究高血压患者感染新冠病毒疾病几率更高的原因;然后我们研究了相关机制,最后,我们报告了高血压患者与运动员之间的异同。总而言之,我们得出结论,经常锻炼的人,与高血压患者一样(代偿机制),由于运动适应导致ACE2浓度升高(生理机制),更容易感染新冠病毒,但由于血管紧张素2水平较低(系统和基因表达),这些个体(活跃受试者)与高血压患者相比,新冠病毒感染的并发症和严重症状如呼吸困难、住院和心脏病更少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7316/9272964/e82890429684/cjim-13-148-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7316/9272964/e82890429684/cjim-13-148-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7316/9272964/e82890429684/cjim-13-148-g001.jpg

相似文献

1
Impact of Hypertension and Physical Fitness on SARS-COV-2 and Related Consequences. (Possible Mechanisms with Focusing on ACE2).高血压和体能对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其相关后果的影响。(聚焦血管紧张素转换酶2(ACE2)的可能机制)
Caspian J Intern Med. 2022;13(Suppl 3):148-154. doi: 10.22088/cjim.13.0.148.
2
SARS-COV-2 in Type 2 Diabetic Patients: Possible Roles of Exercise Training as a Medicine.2 型糖尿病患者中的 SARS-COV-2:运动训练作为一种药物的可能作用。
Curr Diabetes Rev. 2022;18(7):e010921196029. doi: 10.2174/1573399817666210901121824.
3
Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities.生物信息学和系统生物学方法识别 COVID-19 对心血管和高血压合并症的影响。
Brief Bioinform. 2021 Mar 22;22(2):1387-1401. doi: 10.1093/bib/bbaa426.
4
Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality.血管紧张素转换酶2基因插入/缺失多态性与对严重急性呼吸综合征冠状病毒2的易感性、高血压、冠状动脉疾病及2019冠状病毒病死亡率的强关联
J Pers Med. 2021 Oct 27;11(11):1098. doi: 10.3390/jpm11111098.
5
Hypertension and COVID-19: Current Evidence and Perspectives.高血压与 COVID-19:当前的证据和观点。
High Blood Press Cardiovasc Prev. 2022 Mar;29(2):115-123. doi: 10.1007/s40292-022-00506-9. Epub 2022 Feb 20.
6
SARS-CoV-2 and hypertension.SARS-CoV-2 与高血压。
Physiol Rep. 2021 Jun;9(11):e14800. doi: 10.14814/phy2.14800.
7
The Renin-Angiotensin-Aldosterone System and Coronavirus Disease 2019.肾素-血管紧张素-醛固酮系统与2019冠状病毒病
Eur Cardiol. 2021 Mar 9;16:e07. doi: 10.15420/ecr.2020.30. eCollection 2021 Feb.
8
Pregnancy, Preeclampsia, and COVID-19: Susceptibility and Mechanisms: A Review Study.妊娠、子痫前期与2019冠状病毒病:易感性与机制:一项综述研究
Int J Fertil Steril. 2022 Apr;16(2):64-69. doi: 10.22074/IJFS.2022.539768.1194. Epub 2022 May 8.
9
Sex-Specific Modulation of Blood Pressure and the Renin-Angiotensin System by ACE (Angiotensin-Converting Enzyme) 2.血管紧张素转换酶 2 通过(血管紧张素转化酶)对血压和肾素-血管紧张素系统的性别特异性调节。
Hypertension. 2020 Aug;76(2):478-487. doi: 10.1161/HYPERTENSIONAHA.120.15276. Epub 2020 Jun 22.
10
Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells.血管紧张素 II 受体阻滞剂(ARB 类降压药)可增加 SARS-CoV-2 在 Vero E6 细胞中的复制。
Front Cell Infect Microbiol. 2021 Jun 11;11:639177. doi: 10.3389/fcimb.2021.639177. eCollection 2021.

引用本文的文献

1
Sex and diet, but not exercise, alter cardiovascular ACE2 and TMPRSS2 mRNA levels in aortic banded swine.性别和饮食而非运动改变了主动脉缩窄猪的心血管 ACE2 和 TMPRSS2 mRNA 水平。
J Appl Physiol (1985). 2023 Feb 1;134(2):482-489. doi: 10.1152/japplphysiol.00736.2022. Epub 2023 Jan 19.

本文引用的文献

1
Epidemiologic comparison of the first and second waves of coronavirus disease in Babol, North of Iran.伊朗北部巴博勒市新冠病毒疾病第一波和第二波的流行病学比较
Caspian J Intern Med. 2020 Fall;11(Suppl 1):544-550. doi: 10.22088/cjim.11.0.544.
2
The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19.血管紧张素转换酶2的两面性:血管紧张素转换酶2受体及其多态性在高血压和2019冠状病毒病中的作用
Mol Ther Methods Clin Dev. 2020 Jun 25;18:321-327. doi: 10.1016/j.omtm.2020.06.017. eCollection 2020 Sep 11.
3
COVID-19, Renin-Angiotensin System and Endothelial Dysfunction.
新型冠状病毒肺炎、肾素-血管紧张素系统与血管内皮功能障碍。
Cells. 2020 Jul 9;9(7):1652. doi: 10.3390/cells9071652.
4
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.SARS-CoV-2 大流行和研究空白:了解 SARS-CoV-2 与 ACE2 受体的相互作用及其对治疗的影响。
Theranostics. 2020 Jun 12;10(16):7448-7464. doi: 10.7150/thno.48076. eCollection 2020.
5
Emerging mechanisms for the new coronavirus-related myocardial injury and ischemia: A review of the literature.新型冠状病毒相关心肌损伤和缺血的新机制:文献综述
Anatol J Cardiol. 2020 Jul;24(1):7-12. doi: 10.14744/AnatolJCardiol.2020.68166.
6
Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.重组人血管紧张素转换酶2:新型冠状病毒感染及其并发症的潜在治疗方法
Acta Pharmacol Sin. 2020 Sep;41(9):1255-1257. doi: 10.1038/s41401-020-0430-6. Epub 2020 Jun 24.
7
COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance.用于合成疫苗、肽模拟拮抗剂和治疗性药物的 COVID-19 冠状病毒刺突蛋白分析,以及对保守区域阿喀琉斯之踵的分析,以最大程度地降低逃逸突变和耐药性的可能性。
Comput Biol Med. 2020 Jun;121:103749. doi: 10.1016/j.compbiomed.2020.103749. Epub 2020 Apr 11.
8
COVID-19 and hypertension.新型冠状病毒肺炎与高血压
J Renin Angiotensin Aldosterone Syst. 2020 Apr-Jun;21(2):1470320320927851. doi: 10.1177/1470320320927851.
9
ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic: The Pediatric Perspective.ACE2(血管紧张素转化酶 2)、COVID-19 以及大流行期间 ACE 抑制剂和血管紧张素 II(血管紧张素 II)受体阻滞剂的使用:儿科观点。
Hypertension. 2020 Jul;76(1):16-22. doi: 10.1161/HYPERTENSIONAHA.120.15291. Epub 2020 May 5.
10
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19.冠状病毒与 ACE2、血管紧张素 II 和 RAS 抑制剂的相互作用——来自现有证据的教训和对 COVID-19 的深入了解。
Hypertens Res. 2020 Jul;43(7):648-654. doi: 10.1038/s41440-020-0455-8. Epub 2020 Apr 27.